How Will The Female Infertility Market Reach $2.18 Billion By 2029 Amid Global Shifts?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Female Infertility Market?
In recent times, there has been a consistent upswing in the size of the female infertility market. The market is projected to increase from $1.79 billion in 2024 to $1.86 billion in 2025, indicative of a compound annual growth rate (CAGR) of 4.2%. Factors that have contributed to this growth curve in the historical period include an increasing trend of women opting to delay childbirth, lifestyle alterations, proactive government initiatives, a rising aging population, and the advanced prevalence of assisted reproductive technology (ART) treatment.
In the forthcoming years, the market size of female infertility will experience consistent growth. The market is projected to reach $2.18 billion in 2029, with a compound annual growth rate (CAGR) of 4.0%. This expansion in the prediction period is due to heightened awareness about fertility challenges, an escalation in the occurrence of polycystic ovary syndrome, increased cases of uterine irregularities, and a rise in genetic abnormalities incidences, as well as growing obesity. Trends anticipated within this forecast period encompass advancements in preimplantation genetic examination, technological progression, novel diagnostic technologies, fertility preservation, and the use of telemedicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20787&type=smp
What Growth-Enabling Forces Are Impacting The Female Infertility Market?
The female infertility market is anticipated to grow due to the escalating incidence of infertility. Infertility is defined as the inability to become pregnant after a year of regular unprotected sexual activity. This rise in infertility can be attributed to factors such as delayed childbearing, modifications in lifestyle, environmental pollutants, increasing obesity, and heightened stress levels. Female infertility treatment is necessary to identify and manage medical, hormonal or structural problems that hinder fertility, thus improving the likelihood of pregnancy and avoiding enduring infertility. For example, in July 2024, the Human Fertilization and Embryology Authority, a public body in the UK under the umbrella of the Department of Health and Social Care, reported that licensed fertility clinics in the UK conducted nearly 77,000 fresh and frozen embryo transfer IVF cycles for 52,500 patients in 2022. Over 90% of these treatments were done with a partner, involving around 100,000 individuals. Hence, the escalating incidence of infertility is positively impacting the growth of the female infertility market.
How Does The Female Infertility Market Differ By Segment?
The female infertilitymarket covered in this report is segmented –
1) By Treatment: Clomiphene Citrate; Gonadotropins; Metformin; Letrozole; Bromocriptine
2) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
3) By End-User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Clomiphene Citrate: Oral Clomiphene Citrate; Injectable Clomiphene Citrate
2) By Gonadotropins: Recombinant Gonadotropins; Urinary Gonadotropins; Human Chorionic Gonadotropin (hCG)
3) By Metformin: Immediate-Release Metformin; Extended-Release Metformin
4) By Letrozole: Oral Letrozole Tablets; Injectable Letrozole
5) By Bromocriptine: Oral Bromocriptine Tablets; Intranasal Bromocriptine
What New Opportunities Are Emerging From Trends In The Female Infertility Market?
Leading companies in the female infertility market are directing their efforts towards the creation of novel products like non-invasive diagnostic tests as a strategic move to stay competitive in the sector. Non-invasive diagnostic tests, which identify conditions or illnesses without the necessity for surgery or penetration of the body, form an innovative solution. For example, Heranova Lifesciences, an American biotech firm, rolled out an early access program for HerResolve, their proprietary non-invasive diagnostic test for endometriosis in August 2024. With endometriosis impacting nearly 200 million women globally and resulting in infertility, pain, and bleeding; accurate diagnosis can typically take between 7-10 years from when the symptoms first appear. This is primarily due to the diversity of symptom manifestation and the invasive nature of the most dependable diagnostic tool – exploratory laparoscopic surgery. However, HerResolve could potentially shorten this process from years to just a few months, thereby enhancing both the patient’s health journey and healthcare results dramatically.
Who Are The Most Influential Companies In The Female Infertility Market?
Major companies operating in the female infertility market are Pfizer Inc., Roche Holding AG, Merck And Co. Inc, Bayer AG, Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Commonwealth Serum Laboratories Ltd, Organon Theramex, Juniper Reproductive Health Ltd., Sumitomo Pharma, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Co., Mankind Pharma, Kissei Pharmaceutical Co Ltd, ASKA Pharmaceutical Co. Ltd., Fuji Pharma Co. Ltd., ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Hernova Lifesciences Holdings Ltd
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report
Which Region Is Leading Innovation In The Female Infertility Market?
Europe was the largest region in the female infertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20787&type=smp
Browse Through More Reports Similar to the Global Female Infertility Market 2025, By The Business Research Company
Female Fertility And Pregnancy Rapid Test Global Market Report 2025
Pregnancy Test Kits Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pregnancy-test-kits-global-market-report
Assisted Reproductive Technology Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
